The creation of a wholly-owned subsidiary to hold exclusive global licensing rights for all aptamer-based technology could potentially increase Zentek's revenue and market share. This is because the company will have the sole right to commercialize this technology globally, which could lead to increased sales and profits. However, the actual impact will depend on the market demand for this technology and the company's ability to successfully commercialize it.